Matrivax Research and Development Corporation   Report issue

For profit Phase 1
Founded: Boston MA United States (2007)
Status: Left NME R&D (2020)

Organization Overview

First Clinical Trial
2016
NCT03926455
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Matrivax Research and Development Corporation

Active Ingredients

Drugs in Phase 1 Trials (2)

typhax (1 trial)

typhoid vi polysaccharide vaccine (Typhim Vi) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Typhoid Fever (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 2